10-Q: NorthView Acquisition Corp. Grapples with Widening Losses, Nasdaq Delisting, and Going Concern Doubts Amidst Profusa Merger Delays

NorthView Acquisition Corp. reported a widened net loss and a substantial working capital deficit for Q1 2025, alongside its delisting from Nasdaq and ongoing efforts to finalize its business combination with Profusa by an extended June 2025 deadline.

Summary

• NorthView Acquisition Corp. reported a net loss of $(1,119,910) for the three months ended March 31, 2025, a significant increase from the $(820,277) net loss in the same period of 2024.
• The company's cash held in its Trust Account drastically decreased to $1,920,401 as of March 31, 2025, down from $8,330,835 at December 31, 2024, primarily due to substantial share redemptions.
• As of March 31, 2025, NorthView had a working capital deficit of $13,191,353, leading management to express substantial doubt about its ability to continue as a going concern if the business combination is not completed by June 22, 2025.
• The company was delisted from The Nasdaq Stock Market on December 27, 2024, for failing to complete its initial business combination by the required 36-month deadline, with its securities now quoted on the OTC Pink Markets.
• An excise tax liability of $1,946,052 was accrued as of March 31, 2025, due to stock redemptions, with an estimated $39,000 in interest and penalties accrued for unpaid taxes.
• The merger agreement with Profusa, Inc. has been amended multiple times, extending the business combination period to June 22, 2025, and revising earnout milestones, including changing the Milestone Event IV revenue target from $99,702,000 for FY2025 to $11,864,000 for FY2026.
• NorthView entered into a Securities Purchase Agreement on February 11, 2025, for up to $22,222,222 in senior secured convertible promissory notes from an institutional investor, with an initial tranche of $10,000,000 principal expected at the business combination closing.
• Material weaknesses in internal controls over financial reporting were identified as of March 31, 2025, relating to the valuation of financial instruments, recording of certain liabilities, and safeguarding of trust funds.
• Stockholders approved the merger agreement with Profusa, an amended charter, new directors, and employee incentive plans at a special meeting on June 9, 2025.

Sentiment

Score: 2

Explanation: The company faces severe liquidity issues, has been delisted from Nasdaq, and has significant internal control weaknesses. While a potential merger and financing are in progress, the overall financial health and operational challenges present a highly negative outlook, raising substantial doubt about its ability to continue as a going concern.

Positives

• The company secured a Securities Purchase Agreement for up to $22,222,222 in senior secured convertible promissory notes, providing a potential source of funding for the Profusa merger.
• The business combination period with Profusa has been extended to June 22, 2025, allowing additional time to complete the merger.
• Stockholders approved the merger agreement with Profusa and related actions, including charter amendments and new director elections, on June 9, 2025, indicating progress towards the combination.
• A Non-Redemption Agreement was entered into on May 8, 2025, with I-Bankers Securities, Inc. and Dawson James Securities, Inc., which could help mitigate further trust account depletion from redemptions.

Negatives

• Net loss widened significantly to $(1,119,910) for the three months ended March 31, 2025, compared to $(820,277) for the same period in 2024.
• Cash held in the Trust Account decreased substantially from $8,330,835 at December 31, 2024, to $1,920,401 at March 31, 2025, due to high redemption rates.
• The company has a working capital deficit of $13,191,353 as of March 31, 2025, raising substantial doubt about its ability to continue as a going concern.
• NorthView was delisted from Nasdaq on December 27, 2024, and now trades on the less liquid OTC Pink Markets, which can limit investor trading and future financing opportunities.
• An excise tax liability of $1,946,052 has been accrued as of March 31, 2025, with an additional $39,000 in interest and penalties due to unpaid taxes, further straining liquidity.
• Material weaknesses in internal controls over financial reporting were identified, indicating deficiencies in financial reporting processes and controls.
• The earnout revenue target for Profusa's Milestone Event IV was significantly reduced from $99,702,000 for fiscal year 2025 to $11,864,000 for fiscal year 2026, suggesting lower revenue expectations for the target company.
• A previously announced PIPE funding agreement with Vellar Opportunities Fund Master, Ltd. for $5,000,000 was terminated on September 25, 2024.

Risks

• Uncertainty regarding the completion of the Business Combination with Profusa by the extended deadline of June 22, 2025.
• Substantial doubt about the company's ability to continue as a going concern if the Business Combination is not consummated, potentially leading to mandatory liquidation and dissolution.
• Exposure to a 1% U.S. federal excise tax on stock repurchases (redemptions) under the Inflation Reduction Act of 2022, which could reduce cash available for the Business Combination.
• Accrued excise tax liability of $1,946,052 as of March 31, 2025, with additional interest and penalties for unpaid amounts, further straining liquidity.
• Delisting from Nasdaq and trading on the OTC Pink Markets limits investor trading ability, reduces liquidity, and may hinder future capital raises.
• Loss of 'covered securities' status under the National Securities Markets Improvement Act of 1996, potentially subjecting the company to state-level regulation and making the Business Combination more difficult and costly.
• Material weaknesses in internal controls over financial reporting, which could adversely affect the company's ability to record, process, summarize, and report financial information accurately.
• The minimum available cash condition of $15,000,000 for the Profusa merger may not be met.
• The company's agreed waiver of its right to withdraw up to $100,000 of interest from the Trust Account for dissolution expenses and interest for tax expenses limits access to funds for these purposes.

Future Outlook

NorthView Acquisition Corp. is primarily focused on consummating its business combination with Profusa by the extended deadline of June 22, 2025. The company anticipates incurring significant costs in pursuit of this merger and acknowledges substantial doubt about its ability to continue as a going concern if the combination is not completed. Future financing efforts include tranches from a new Securities Purchase Agreement, contingent on the merger closing and other conditions. The company also expects to continue incurring expenses as a public company, despite its delisting from Nasdaq, and will need to address its accrued excise tax liabilities.

Management Comments

• "Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Companys ability to continue as a going concern for the next twelve months from the issuance of these condensed consolidated financial statements."
• "We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful."
• "We expect to incur significant costs in the pursuit of our initial Business Combination."

Industry Context

NorthView Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC), a sector that has seen increased scrutiny and challenges, particularly regarding the ability to complete business combinations within mandated timelines. The company's delisting from Nasdaq due to its failure to complete a merger within 36 months is a common issue faced by SPACs that struggle to identify or finalize suitable targets, leading to reduced liquidity and investor interest as trading shifts to less regulated OTC markets. The repeated extensions of the business combination deadline and significant share redemptions reflect broader market trends where SPACs face pressure from investors to either complete a deal or return capital, often resulting in a shrinking trust account. The recalibration of earnout milestones for Profusa also suggests a more conservative outlook, which is not uncommon in complex SPAC mergers.

Comparison to Industry Standards

• NorthView's significant share redemptions, leading to a drastic reduction in its trust account from an initial $191.6 million to $1.9 million, are indicative of a common trend among SPACs where public shareholders redeem their shares rather than participate in a de-SPAC transaction, especially as deadlines approach or market conditions become unfavorable. This contrasts sharply with successful SPACs that maintain high trust account balances or attract significant PIPE investments.
• The delisting from Nasdaq and subsequent trading on the OTC Pink Markets is a clear underperformance compared to industry standards, where the primary goal of a SPAC is to list the combined entity on a major exchange like Nasdaq or NYSE. This move significantly reduces liquidity and investor visibility, unlike peers that successfully transition to a major exchange post-merger.
• The repeated extensions of the business combination deadline (from March 2023 to June 2025) and the associated costs and redemptions are typical of SPACs facing difficulties in closing a deal, but the extent of redemptions and the prolonged timeline highlight significant challenges compared to more efficient SPAC processes.
• The identified material weaknesses in internal controls over financial reporting are a serious concern, indicating a failure to meet fundamental corporate governance and financial reporting standards expected of publicly traded companies, regardless of their size or stage. This contrasts with well-managed public companies that maintain robust internal control environments.
• The accrual of a substantial excise tax liability ($1.9 million) due to redemptions, coupled with penalties for non-payment, reflects a financial burden that many SPACs, particularly those with high redemption rates, are now facing under the Inflation Reduction Act, a relatively new industry-wide challenge.

Management Changes

Corporate Governance

Related Party Transactions

• Convertible Working Capital Promissory Note with NorthView Sponsor I, LLC: Principal outstanding of $1,919,796, fair value $9,133,382 as of March 31, 2025. Amended multiple times to increase principal amount to $2.5 million and allow conversion into common stock at $2.22 per share.
• Advances from Profusa: $1,176,565 owed as of March 31, 2025, for operating expenses, due upon demand or completion of Business Combination.
• Due to related party: $41,180 as of March 31, 2025, primarily related to unpaid administrative service fees ($50,000) and a payment made on behalf of the Sponsor ($8,820 reduction).
• Founder Shares: Sponsor paid $25,000 for 5,175,000 shares, later adjusted to 4,743,750 shares. Subject to lock-up period.
• Private Placement Warrants: Sponsor purchased 5,162,500 warrants at $1.00 per warrant.
• Administrative Service Fee: $5,000 per month paid to Sponsor for office space and services, terminated June 30, 2023, but $50,000 remains unpaid.

Stakeholder Impact

• Shareholders: Face significant dilution risk from warrant exercises and convertible notes. High redemption rates indicate dissatisfaction or lack of confidence. Delisting from Nasdaq reduces liquidity and market access for existing shareholders. Uncertainty about the business combination completion and going concern raises significant investment risk.
• Employees: Not directly applicable for a SPAC with minimal operations. Post-merger, Profusa employees would be impacted by the combined entity's strategic direction and financial stability.
• Customers: Not applicable for a SPAC. Post-merger, Profusa's customers would be impacted by the combined entity's strategic direction and financial stability.
• Suppliers/Creditors: The company's working capital deficit and going concern doubt pose risks to creditors, as repayment ability is uncertain without the business combination. Unpaid excise taxes and related penalties also represent a significant liability.
• Sponsor: Continues to provide financing through convertible notes and has waived certain rights, indicating ongoing commitment but also exposure to the company's financial distress and potential loss of investment.

Next Steps

• Consummate the Business Combination with Profusa by June 22, 2025.
• Complete the initial closing of the Securities Purchase Agreement for convertible notes upon the Business Combination.
• Address and remediate identified material weaknesses in internal controls over financial reporting.
• File a registration statement for shares underlying the initial convertible notes and maintain its effectiveness.
• Potentially call for additional tranches of convertible notes from the institutional investor, subject to performance conditions.
• Profusa to consummate the APAC Joint Venture and receive related funding by December 31, 2025.
• Profusa to achieve an earnout revenue target of $11,864,000 for the fiscal year ended December 31, 2026, for Milestone Event IV.
• Pay the accrued excise tax liability and associated interest and penalties.

Key Dates

Recommendation

Keywords

SPAC, Special Purpose Acquisition Company, NorthView Acquisition Corp., NVAC, Profusa, Business Combination, Merger, 10-Q, Quarterly Report, SEC Filing, Financial Results, Liquidity, Going Concern, Nasdaq Delisting, OTC Markets, Stock Redemptions, Excise Tax, Convertible Promissory Note, Securities Purchase Agreement, Internal Controls, Financial Reporting, Corporate Governance